NCT04869137 2026-04-08
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
University of Utah
Klein Buendel, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
H. Lee Moffitt Cancer Center and Research Institute